IS THERE A CONNECTION BETWEEN ORAL AND MENTAL HEALTH

Mental health is linked to oral health, and vice versa. Good oral health can enhance mental and overall health, while poor oral health can exacerbate mental issues. Likewise, mental conditions can cause oral health issues. The connection between them is direct, cyclical and, when oral health is neglected, detrimental.

….FULL ARTICLE

DIABETES AND YOUR TEETH

Diabetes may cause serious problems with keeping your mouth healthy and having an attractive smile. The disease causes difficulties in the mouth, and problems in the mouth may cause trouble with diabetes. With diabetes, glucose is present in the saliva. When diabetes is not controlled, increased glucose in the saliva allows harmful bacteria to grow.   Periodontal disease, also known as gum disease, is the most widespread chronic inflammatory condition worldwide, says Dr. Wayne Aldredge.

….FULL ARTICLE

SMART APPS FOR DENTAL HEALTH CARE

Oral health is often taken for granted. The mouth is a window into the health of the entire body. It can show signs of nutritional deficiencies or general infection. Systemic diseases – those that affect the entire body – may first become apparent because of mouth lesions or other oral problems.   Regardless of age, oral health is very important. Positive oral health leads to improved overall health. More Americans today are keeping their natural teeth throughout their lives.

….FULL ARTICLE

Use the buttons below to scroll through more great articles on health and wellness issues

MORE ARTICLES

Be Sociable, Share!

Share on Facebook Share on Twitter Share on Delicious Share on Digg Share on Google Bookmarks Share on LinkedIn Share on LiveJournal Share on Newsvine Share on Reddit Share on Stumble Upon Share on Tumblr

MORE FEATURE ARTICLES

CONTACT INFORMATION

© Health & Wellness Magazine - All rights reserved | Designed and Maintained by PurplePatch Innovations

MORE FROM ROCKPOINT PUBLISHING

HEALTH & WELLNESS MAGAZINE

HOME | FEATURE ARTICLES | COLUMNS | DIGITAL ISSUES | CALENDAR | RACE RUNNING CALENDAR | ABOUT | CONTACT

subscribe to Health & Wellness


The results of two new randomized and controlled mental health research studies demonstrated that just one dose of psilocybin produces significant long-term improvements in patients with anxiety and depression. These findings, recently published in The Journal of Psychopharmacology, are potentially beneficial for individuals who are troubled by anxiety and depression.


Psilocybin is a hallucinogenic substance obtained from certain types of mushrooms indigenous to tropical and subtropical regions of South America, Mexico and the United States. Fifty-one adults participated in the double-blind crossover study at Johns Hopkins University. New York University was the second site. Stephen Ross, M.D., principal investigator of the NYU study and director of substance abuse services in the Department of Psychiatry at Langone Medical Center, said all patients received targeted counseling plus a 0.3 mg/kg dose of psilocybin at one of two treatment sessions. A vitamin placebo at the other session realized 80 percent of the subjects experienced a significant reduction in anxiety and depressive symptoms after six months. Furthermore, 80 percent of the subjects realized clinically significant decreases in symptomology six months after their final treatment session, suggesting there may be longer term benefits with less need for medication.


Further research with larger samples needs to be conducted,

INNOVATIVE RESEARCH FINDINGS SUGGEST NEW DIRECTION IN MENTAL HEALTH CARE

but it is clear these initial findings raise the issue that psilocybin holds true potential for treating anxiety and depression in patients with this diagnosis. These results represent a dramatic step forward in the mental health profession’s efforts to help some of the most seriously affected patients needing a more effective protocol of care and treatment for anxiety and depression.


Sources and Resources:


•  Hallucinogenic drug psilocybin eases existential anxiety in people with life threatening cancer. Baltimore, MD: Johns Hopkins University School of Medicine; December 1, 2016.

•  Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer. New York, NY: New York University Langone Medical Center; December 1, 2016.

DR. THOMAS W. MILLER, PH.D, ABPP

Thomas W. Miller, Ph.D., ABPP, is a professor emeritus and senior research scientist, Center for Health, Intervention and Prevention, University of Connecticut; retired service chief from the VA Medical Center; and tenured professor in the Department of Psychiatry, College of Medicine, University of Kentucky.

more articles by Dr thomas w. miller